Lutalyse
Brand names,
Lutalyse
Analogs
Lutalyse
Brand Names Mixture
Lutalyse
Chemical_Formula
C23H36O3
Lutalyse
RX_link
No information avaliable
Lutalyse
fda sheet
Lutalyse
msds (material safety sheet)
Lutalyse
Synthesis Reference
No information avaliable
Lutalyse
Molecular Weight
360.53 g/mol
Lutalyse
Melting Point
128 oC
Lutalyse
H2O Solubility
No information avaliable
Lutalyse
State
Solid
Lutalyse
LogP
4.566
Lutalyse
Dosage Forms
Solution for injection
Lutalyse
Indication
For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
Lutalyse
Pharmacology
Dromostanolone is a synthetic androgen, or male hormone, similar to testosterone. Dromostanolone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.
Lutalyse
Absorption
Well absorbed following parenteral administration.
Lutalyse
side effects and Toxicity
Side effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.
Lutalyse
Patient Information
No information avaliable
Lutalyse
Organisms Affected
Humans and other mammals